Container system and method for freezing and thawing a liquid product

Patent metadata

Field	Value
Publication number	US-12016330-B2
Application number	US-202117545118-A
Country	US
Kind code	B2
Filing date	Dec 8, 2021
Priority date	Aug 24, 2016
Publication date	Jun 25, 2024
Grant date	Jun 25, 2024

Abstract

Container system and method for freezing (and subsequently thawing) a liquid such as a drug substance, such that all containers in a set have a uniform width, hence uniform freeze-path length, in the widthwise direction and perpendicular to major walls of the containers, irrespective of the particular length, height, and volumetric capacity of the various containers in the set. This leads to uniform freezing performance and thereby reduces cryoconcentration. The system also eliminates or reduces ice-bridging, and the potential for containers rupturing during freezing and thawing operations.

First claim

We claim:

1. A system to produce frozen pharmaceutical product in a plurality of bulk amounts simultaneously, comprising:
a blast freezer with a refrigeration chamber through which a predetermined cooling medium flows in a predetermined flow direction at a predetermined flow velocity and at a predetermined temperature; and
a plurality of containers disposed within the refrigeration chamber and each containing an amount of liquid pharmaceutical product to be frozen to produce the frozen pharmaceutical product, with each of the containers having a lengthwise dimension that is aligned with the flow direction and two parallel, major sidewalls that are spaced from each other in a widthwise direction and with the plurality of containers being arranged within the refrigeration chamber so that the cooling medium flows along at least one of the two major sidewalls of each container during freezing operation of the blast freezer, wherein the two major sidewalls of each of the containers in the plurality of containers are spaced from each other by the same distance so that a freeze-path length associated with each of the containers in the plurality of containers is the same, the amount of liquid pharmaceutical product contained in each of the containers being set to be less than a total internal volume of the respective container such that a headspace exists within the container above an upper surface of the liquid pharmaceutical product contained within the container, the total internal volume of at least two of the containers in the plurality of containers differing from each other;
wherein an ice bridging number (IBN) associated with each of the containers in the plurality of containers is less than 0.6, whereby the liquid pharmaceutical product in a given container tends to freeze within the given container along the major sidewalls of the given container at a faster rate than the liquid pharmaceutical product tends to freeze at an upper surface thereof so that ice-bridging is suppressed;
the ice bridging number being a dimensionless parameter that A) reflects comparative rates of heat transfer through the headspace above the liquid pharmaceutical product in a given container and through the major sidewalls of the given container with which the liquid pharmaceutical product is in contact and B) that is indicative of relative rates at which water in the liquid pharmaceutical product tends to freeze at the air-liquid interface at the upper surface of the liquid pharmaceutical product in the container and along the major sidewalls of the given container, and
the IBN for a given container containing liquid pharmaceutical product therein being a function of container dimensions and geometry; heat transfer areas; amount of liquid pharmaceutical product contained within the given container; heat transfer coefficients for the material from which the given container is made, the liquid pharmaceutical product, and the predetermined cooling medium; thermal properties of the pharmaceutical product before and after freezing; and the predetermined flow velocity and predetermined temperature of the predetermined cooling medium.

2. The system according to claim 1 , wherein the plurality of containers are all arranged within the refrigeration chamber so that the cooling medium flows along both of the two major sidewalls of each container during freezing operation of the blast freezer.

3. The system according to claim 2 , wherein the plurality of containers are all arranged with bottom walls thereof disposed against a heat-conducting metal surface to facilitate heat transfer and freezing of the liquid pharmaceutical product at bottom portions of the containers.

4. The system according to claim 1 , further comprising a plurality of insulating shrouds, with one shroud disposed over a top portion of each of the containers in the plurality of containers to insulate, and thereby limit heat transfer through, the headspace in a given container.

5. A system to produce frozen pharmaceutical product in a plurality of bulk amounts simultaneously, comprising:
a blast freezer with a refrigeration chamber through which a predetermined cooling medium flows in a predetermined flow direction at a predetermined flow velocity and at a predetermined temperature; and
a plurality of containers disposed within the refrigeration chamber and each containing an amount of liquid pharmaceutical product to be frozen to produce the frozen pharmaceutical product, with each of the containers having a lengthwise dimension that is aligned with the flow direction and two parallel, major sidewalls that are spaced from each other in a widthwise direction and with the plurality of containers being arranged within the refrigeration chamber so that the cooling medium flows along at least one of the two major sidewalls of each container during freezing operation of the blast freezer, wherein the two major sidewalls of each of the containers in the plurality of containers are spaced from each other by the same distance so that a freeze-path length associated with each of the containers in the plurality of containers is the same, the amount of liquid pharmaceutical product contained in each of the containers being set to be less than a total internal volume of the respective container such that a headspace exists within the container above an upper surface of the liquid pharmaceutical product contained within the container, the total internal volume of at least two of the containers in the plurality of containers differing from each other;
wherein an ice bridging number (IBN) associated with each of the containers in the plurality of containers is the same, the ice bridging number being a dimensionless parameter that A) reflects comparative rates of heat transfer through the headspace above the liquid pharmaceutical product in a given container and through the major sidewalls of the given container with which the liquid pharmaceutical product is in contact and B) that is indicative of relative rates at which water in the liquid pharmaceutical product tends to freeze at the air-liquid interface at the upper surface of the liquid pharmaceutical product in the container and along the major sidewalls of the given container, and
the IBN for a given container containing liquid pharmaceutical product therein being a function of container dimensions and geometry; heat transfer areas; amount of liquid pharmaceutical product contained within the given container; heat transfer coefficients for the material from which the given container is made, the liquid pharmaceutical product, and the predetermined cooling medium; thermal properties of the pharmaceutical product before and after freezing; and the predetermined flow velocity and predetermined temperature of the predetermined cooling medium.

6. The system according to claim 5 , wherein the plurality of containers are all arranged within the refrigeration chamber so that the cooling medium flows along both of the two major sidewalls of each container during freezing operation of the blast freezer.

7. The system according to claim 6 , wherein the plurality of containers are all arranged with bottom walls thereof disposed against a heat-conducting metal surface to facilitate heat transfer and freezing of the liquid pharmaceutical product at bottom portions of the containers.

8. The system according to claim 5 , further comprising a plurality of insulating shrouds, with one shroud disposed over a top portion of each of the containers in the plurality of containers to insulate, and thereby limit heat transfer through, the headspace in a given container.

9. A system to produce frozen pharmaceutical product in a plurality of bulk amounts simultaneously, comprising:
a blast freezer wit

Assignees

• Merck Sharp & Dohme Llc

Inventors

• Johnson Jeffrey Charles
• Flammino Anthony
• Petrich Mark Anton
• Mcfeaters Scott
• Roosa Jr John H
• Alpern Robert Ian
• Locurcio Joseph W
• Flamm Matthew H

Classifications

• A01N1/147 Primary

  Carriers for immersion in cryogenic fluid for slow freezing or vitrification · CPC title

• A01N1/146

  Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving · CPC title

• A01N1/148

  with provisions specially adapted for transporting · CPC title

• B65D81/24

  Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants (with thermal insulation B65D81/38) · CPC title

• B65D81/18

  providing specific environment for contents, e.g. temperature above or below ambient (with thermal insulation B65D81/38) · CPC title